Diagnosing Diabetic Neuropathy: Something Old, Something New
Year: 2018
Type: review
Abstract: evaluation of sensory C-fibers. An increasing body of evidence from multiple centers worldwide suggests that CCM fulfills the FDA criteria as a surrogate endpoint of DPN.
Source: Diabetes & Metabolism Journal
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $500
OpenAlex ID: W2888017189
